These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Multi-organ sarcoidosis treatment with fumaric acid esters: a case report and review of the literature. Zouboulis CC; Lippert U; Karagiannidis I Dermatology; 2014; 228(3):202-6. PubMed ID: 24686198 [TBL] [Abstract][Full Text] [Related]
10. Use of fumaric acid esters in psoriasis. Roll A; Reich K; Boer A Indian J Dermatol Venereol Leprol; 2007; 73(2):133-7. PubMed ID: 17456929 [TBL] [Abstract][Full Text] [Related]
11. Improving the Gastrointestinal Tolerability of Fumaric Acid Esters: Early Findings on Gastrointestinal Events with Diroximel Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis from the Phase 3, Open-Label EVOLVE-MS-1 Study. Palte MJ; Wehr A; Tawa M; Perkin K; Leigh-Pemberton R; Hanna J; Miller C; Penner N Adv Ther; 2019 Nov; 36(11):3154-3165. PubMed ID: 31538304 [TBL] [Abstract][Full Text] [Related]
12. Dimethyl fumarate (DMF) vs. monoethyl fumarate (MEF) salts for the treatment of plaque psoriasis: a review of clinical data. Landeck L; Asadullah K; Amasuno A; Pau-Charles I; Mrowietz U Arch Dermatol Res; 2018 Aug; 310(6):475-483. PubMed ID: 29574575 [TBL] [Abstract][Full Text] [Related]
13. [Efficacy and safety profile of fumaric acid esters in oral long-term therapy with severe treatment refractory psoriasis vulgaris. A study of 83 patients]. Altmeyer P; Hartwig R; Matthes U Hautarzt; 1996 Mar; 47(3):190-6. PubMed ID: 8647701 [TBL] [Abstract][Full Text] [Related]
14. Fumaric acid esters in recalcitrant pediatric psoriasis: A prospective, daily clinical practice case series. van Geel MJ; van de Kerkhof PC; Oostveen AM; de Jong EM; Seyger MM J Dermatolog Treat; 2016; 27(3):214-20. PubMed ID: 26452994 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, Fumaderm Mrowietz U; Szepietowski JC; Loewe R; van de Kerkhof P; Lamarca R; Ocker WG; Tebbs VM; Pau-Charles I Br J Dermatol; 2017 Mar; 176(3):615-623. PubMed ID: 27515097 [TBL] [Abstract][Full Text] [Related]
16. Switching from a fumaric acid ester mixture to dimethylfumarate monotherapy in psoriasis. Warren RB; Barker JNW; Van de Kerkhof P; Reich K; Mrowietz U J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):e352-e353. PubMed ID: 31033034 [No Abstract] [Full Text] [Related]
17. Clinical use of dimethyl fumarate in moderate-to-severe plaque-type psoriasis: a European expert consensus. Mrowietz U; Barker J; Boehncke WH; Iversen L; Kirby B; Naldi L; Reich K; Tanew A; van de Kerkhof PCM; Warren RB J Eur Acad Dermatol Venereol; 2018 Oct; 32 Suppl 3():3-14. PubMed ID: 30238510 [TBL] [Abstract][Full Text] [Related]
18. Fumaric acid esters in necrobiosis lipoidica: results of a prospective noncontrolled study. Kreuter A; Knierim C; Stücker M; Pawlak F; Rotterdam S; Altmeyer P; Gambichler T Br J Dermatol; 2005 Oct; 153(4):802-7. PubMed ID: 16181464 [TBL] [Abstract][Full Text] [Related]